MedPath

Cefdinir

CEFDINIR FOR ORAL SUSPENSION

Approved
Approval ID

a9c339ac-14a5-465e-a4fe-1d361d017ccf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 26, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefdinir

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-622
Application NumberANDA065473
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefdinir
Product Specifications
Route of AdministrationORAL
Effective DateDecember 16, 2009
FDA Product Classification

INGREDIENTS (9)

CEFDINIRActive
Quantity: 250 mg in 5 mL
Code: CI0FAO63WC
Classification: ACTIB
SUCROSEInactive
Code: C151H8M554
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
GUAR GUMInactive
Code: E89I1637KE
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95K
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefdinir - FDA Drug Approval Details